The use of selective serotonin reuptake inhibitors (SSRIs) in paediatric patients has not declined "despite warnings from regulatory authorities"

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.494, 2006-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective serotonin reuptake inhibitors (SSRIs) should include a warning about suicide

By  

Inpharma, Vol. 1, Iss. 1261, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1846-1863

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Selective Serotonin Reuptake Inhibitors in Children and Adolescents

By Ian C.K. Wong  

Drug Safety, Vol. 27, Iss. 13, 2004-01 ,pp. : 991-1000

Adis International

Access to resources Recommend Favorite

Use of selective serotonin reuptake inhibitors during pregnancy and breastfeeding has both benefits and risks

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 3, 2006-03 ,pp. : 22-26

Adis International

Access to resources Recommend Favorite

Polymorphism of the Serotonin Transporter: Implications for the Use of Selective Serotonin Reuptake Inhibitors

By Lotrich F.E.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 3, 2001-01 ,pp. : 153-164

Adis International

Access to resources Recommend Favorite